1969
DOI: 10.1002/jps.2600581220
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Dissolution Rates of Aminorex Dosage Forms and Their Correlation with in vivo Availability

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

1971
1971
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 8 publications
(1 reference statement)
0
7
0
Order By: Relevance
“…148 ■ PHARMACOKINETICS Aminorex, when available as an anorectic drug, existed in the form of 7.5−20 mg aminorex fumarate, base or pamoate tablets, to be consumed orally. 211 4-MAR seems to mostly have 189 Hereford calves an increase in arterial blood pressure but no pulmonary side-effects after daily i.v. injections (0.25 mg/kg) for one month were reported Byrne-Quinn and Grover 28 Sprague−Dawley rats dose of 1.5 μmol/kg, administered i.v., elicited increased motor activity; stereotypical behavior was not detected in doses up to 112 μmol/kg Costa et al 37 Wistar rats after administration of 6.5 to 22 mg/kg aminorex daily for 118 consecutive days, no anatomical differences in the pulmonary vessels were detectable Engelhardt and Hort 32 humans this retrospective study highlighted that anticoagulant therapy with warfarin in aminorex-caused pulmonary hypertension had beneficial effects on survival time Frank et al 190 rabbits aminorex was found to be an efficient 5-HT releaser in platelets, similar in potency to amphetamine Fristrom et al 191 human subjects two studies (79 and 60 subjects) have proven aminorex (7.5 mg) to be an effective anorectic agent, similar to dextroamphetamine and diethylpropion but more effective than phenmetrazine; side-effects concerning the CNS, the GI tract and the renal system, as well as leukopenia were reported Hadler 14 mongrel cats 1.0 mg/kg i.p.…”
Section: Actionmentioning
confidence: 96%
See 3 more Smart Citations
“…148 ■ PHARMACOKINETICS Aminorex, when available as an anorectic drug, existed in the form of 7.5−20 mg aminorex fumarate, base or pamoate tablets, to be consumed orally. 211 4-MAR seems to mostly have 189 Hereford calves an increase in arterial blood pressure but no pulmonary side-effects after daily i.v. injections (0.25 mg/kg) for one month were reported Byrne-Quinn and Grover 28 Sprague−Dawley rats dose of 1.5 μmol/kg, administered i.v., elicited increased motor activity; stereotypical behavior was not detected in doses up to 112 μmol/kg Costa et al 37 Wistar rats after administration of 6.5 to 22 mg/kg aminorex daily for 118 consecutive days, no anatomical differences in the pulmonary vessels were detectable Engelhardt and Hort 32 humans this retrospective study highlighted that anticoagulant therapy with warfarin in aminorex-caused pulmonary hypertension had beneficial effects on survival time Frank et al 190 rabbits aminorex was found to be an efficient 5-HT releaser in platelets, similar in potency to amphetamine Fristrom et al 191 human subjects two studies (79 and 60 subjects) have proven aminorex (7.5 mg) to be an effective anorectic agent, similar to dextroamphetamine and diethylpropion but more effective than phenmetrazine; side-effects concerning the CNS, the GI tract and the renal system, as well as leukopenia were reported Hadler 14 mongrel cats 1.0 mg/kg i.p.…”
Section: Actionmentioning
confidence: 96%
“…Aminorex, when available as an anorectic drug, existed in the form of 7.5 to 20 mg aminorex fumarate, base or pamoate tablets, to be consumed orally211. 4-MAR seems to mostly have been ingested orally, insufflated or smoked in doses ranging from 5 to >25 mg depending on the routes of administration212.…”
Section: Pharmacokineticsmentioning
confidence: 99%
See 2 more Smart Citations
“…Using an a priori assumption that a correlation exists between in vitro dissolution and in vivo availability, Cressman et al (375) evaluated changes in dosage form release characteristics in vitro before in viuo determination of total plasma radioactivity in man. Aminorex base, fumarate, and pamoate were used in solution, regular tablet, or timed-release tablet forms or, in the case of the pamoate and fumarate, in more than one dosage form.…”
Section: Biopharmaceuticsmentioning
confidence: 99%